Business Description
Heartseed Inc. is a Tokyo-based biotechnology company founded in 2015 that uses stem cell technology to develop treatments for heart failure. Its main focus is creating replacement heart muscle cells grown from reprogrammed human cells, with its lead therapy targeting patients whose hearts cannot pump blood effectively due to conditions like dilated cardiomyopathy. The company has also built a range of supporting technologies to produce and refine these cell-based treatments at scale.
